Publication | Closed Access
The effects of S-allylmercaptocaptopril, the synthetic product of allicin and captopril, on cardiovascular risk factors associated with the metabolic syndrome
27
Citations
24
References
2005
Year
Metabolic SyndromeMedicineClinical PharmacologyPharmacotherapyCardiovascular Risk FactorsPharmacologySynthetic ProductDrug DiscoveryTranslational Pharmacology
| Year | Citations | |
|---|---|---|
Page 1
Page 1